- n the deep vascular inner layer of the skin
News & Articles
- Corium International, Inc. Files Registration Statement for Proposed Initial Public Offering
MENLO PARK, Calif., March 3, 2014 /PRNewswire/ -- Corium International, Inc., a commercial stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal pharmaceutical products, announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of its ...
March 3, 2014 - PR Newswire via Yahoo! Finance
- Drug delivery modifier Corium International files for a $50 million IPO
Drug delivery modifier Corium International files for a $50 million IPO
March 3, 2014 - Nasdaq